CALL/AMGEN/350/0.1/17.01.25 | Real-time BOERSE MUENCHEN 11:57:20 23/05/2024 pm IST | ||
| 1.4 EUR | -8.50% |
|
| Current month | +200.00% | ||
| 1 month | +210.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 1.4 | -8.50% |
| 22/24/22 | 1.53 | 0.00% |
| 21/24/21 | 1.53 | -2.55% |
| 20/24/20 | 1.57 | +3.97% |
| 17/24/17 | 1.51 | -6.21% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 11:57 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ8XRX |
| ISIN | DE000GZ8XRX3 |
| Date issued | 17/02/2023 |
| Strike | 350 $ |
| Maturity | 17/01/2025 (239 Days) |
| Parity | 10 : 1 |
| Emission price | 0.3 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.3 € |
|---|---|
| Lowest since issue | 0.096 € |
| Delta | 0.35x |
| Omega | 7.299 |
| Premium | 18.78x |
| Gearing | 20.67x |
| Moneyness | 0.8777 |
| Difference Strike | 43.71 $ |
| Difference Strike % | +12.49% |
| Spread | 0.03 € |
| Spread % | 2.16% |
| Theoretical value | 1.345 |
| Implied Volatility | 28.00 % |
| Total Loss Probability | 72.61 % |
| Intrinsic value | 0.000000 |
| Present value | 1.345 |
| Break even | 364.54 € |
| Theta | -0.04x |
| Vega | 0.08x |
| Rho | 0.06x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Warrants
- Warrant
